Sanofi taps new EVPs in commercial operations re-org

Sanofi ($SNY) is rejigging its commercial operations, with two new executive vice presidents stepping up to the plate to replace the retiring global operations President Hanspeter Spek. Peter Guenter will take over global commercial operations, while Pascale Witz, joining Sanofi from GE Healthcare, will handle several divisions, including diabetes, while collaborating with R&D and helping prepare for new drug launches. Release

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.